The promise of biomarkers in cancer screening and detection, Trends Mol Med, vol.8, pp.288-93, 2002. ,
The cancer biomarker problem, Nature, vol.452, pp.548-52, 2008. ,
Enabling personalized cancer medicine through analysis of geneexpression patterns, Nature, vol.452, pp.564-70, 2008. ,
KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab, J Clin Oncol, vol.26, pp.374-383, 2008. ,
URL : https://hal.archives-ouvertes.fr/hal-00363737
Analysis of PTEN, BRAF, and EGFR status in determining benefit from cetuximab therapy in wild-type KRAS metastatic colon cancer, J Clin Oncol, vol.27, pp.5924-5954, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-00618089
KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer, Cancer Res, vol.66, pp.3992-3997, 2006. ,
Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60 -00 trial, J Clin Oncol, vol.28, pp.466-74, 2010. ,
Detection of freecirculating tumor-associated DNA in plasma of colorectal cancer patients and its association with prognosis, Int J Cancer, vol.100, pp.542-550, 2002. ,
Current status and future potential of somatic mutation testing from circulating free DNA in patients with solid tumours, HUGO J, vol.4, pp.11-21, 2010. ,
Cell-free nucleic acids as biomarkers in cancer patients, Nat Rev Cancer, vol.11, pp.426-463, 2011. ,
Detection of tumor PIK3CA status in metastatic breast cancer using peripheral blood, Clin Cancer Res, vol.18, pp.3462-3471, 2012. ,
Exploring the genomes of cancer cells: progress and promise, Science, vol.331, pp.1553-1561, 2011. ,
Circulating mutant DNA to assess tumor dynamics, Nat Med, vol.14, pp.985-90, 2008. ,
Biomarkers in cancer staging, prognosis and treatment selection, Nat Rev Cancer, vol.5, pp.845-56, 2005. ,
Quantitation of targets for PCR by use of limiting dilution, Biotechniques, vol.13, pp.444-453, 1992. ,
, Proc Natl Acad Sci U S A, vol.96, pp.9236-9277, 1999.
Digital PCR hits its stride, Nat Methods, vol.9, pp.541-545, 2012. ,
Detecting biomarkers with microdroplet technology, Trends Mol Med, vol.18, pp.405-421, 2012. ,
URL : https://hal.archives-ouvertes.fr/inserm-02299585
Transforming single DNA molecules into fluorescent magnetic particles for detection and enumeration of genetic variations, Proc Natl Acad Sci U S A, vol.100, pp.8817-8839, 2003. ,
Single-molecule PCR using water-in-oil emulsion, J Biotechnol, vol.102, pp.117-141, 2003. ,
Microdroplets in microfluidics: an evolving platform for discoveries in chemistry and biology, Angew Chem Int Ed Engl, vol.49, pp.5846-68, 2010. ,
Quantitative and sensitive detection of rare mutations using droplet-based microfluidics, Lab Chip, vol.11, pp.2156-66, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-02148770
Highthroughput droplet digital PCR system for absolute quantitation of DNA copy number, Anal Chem, vol.83, pp.8604-8614, 2011. ,
Evaluation of a droplet digital polymerase chain reaction format for DNA copy number quantification, Anal Chem, vol.84, pp.1003-1014, 2012. ,
1-Million droplet array with wide-field fluorescence imaging for digital PCR, Lab Chip, vol.11, pp.3838-3883, 2011. ,
Multiplex digital PCR: breaking the one target per color barrier of quantitative PCR, Lab Chip, vol.11, pp.2167-74, 2011. ,
URL : https://hal.archives-ouvertes.fr/inserm-02299588
Prognostic and predictive factors in colorectal cancer: Kirsten Ras in CRC (RASCAL) and TP53CRC collaborative studies, Ann Oncol, vol.16, issue.4, pp.44-53, 2005. ,
Competitive allele specific TaqMan PCR for KRAS, BRAF and EGFR mutation detection in clinical formalin fixed paraffin embedded samples, Exp Mol Pathol, vol.92, pp.275-80, 2012. ,
DNA preparation from sexual assault cases by selective degradation of contaminating DNA from the victim, J Forensic Sci, vol.54, pp.1297-303, 2009. ,
Multiplex picoliter-droplet digital PCR for quantitative assessment of DNA integrity in clinical samples, Clin Chem, vol.59, pp.815-838, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-02299583
Circulating free DNA in plasma or serum as biomarker of carcinogenesis: practical aspects and biological significance, Mutat Res, vol.635, pp.105-122, 2007. ,
Quantitative cell-free DNA, KRAS, and BRAF mutations in plasma from patients with metastatic colorectal cancer during treatment with cetuximab and irinotecan, Clin Cancer Res, vol.18, pp.1177-85, 2012. ,
Quantitative detection of EGFR mutations in circulating tumor DNA derived from lung adenocarcinomas, Clin Cancer Res, vol.17, pp.7808-7823, 2011. ,
KRAS mutation analysis: a comparison between primary tumours and matched liver metastases in 305 colorectal cancer patients, Br J Cancer, vol.104, pp.1020-1026, 2011. ,
High concordance of KRAS status between primary colorectal tumors and related metastatic sites: implications for clinical practice, Oncologist, vol.13, pp.1270-1275, 2008. ,
Evaluation of fluorescence-based methods for total vs. amplifiable DNA quantification in plasma of lung cancer patients, J Physiol Pharmacol, vol.59, issue.6, pp.675-81, 2008. ,
Dynamics of targeted cancer therapy, Trends Mol Med, vol.18, pp.311-317, 2012. ,
Identification of high-confidence somatic mutations in whole genome sequence of formalin-fixed breast cancer specimens, Nucleic Acids Res, vol.40, p.107, 2012. ,
BEAMing up personalized medicine: mutation detection in blood, Clin Cancer Res, vol.18, pp.3209-3220, 2012. ,
The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers, Nature, vol.486, pp.537-577, 2012. ,